APA (7th ed.) Citation

Goss, P., Mamounas, E., Jakesz, R., Markopoulos, C., Dowsett, M., Peto, R., . . . Davies, C. (2009). Aromatase Inhibitors (AIs) Versus Not (Placebo/Observation) as Late Extended Adjuvant Therapy for Postmenopausal Women with Early Stage Breast Cancer (BC): Overviews of Randomized Trials of AIs after similar to 5 Years of Tamoxifen.

Chicago Style (17th ed.) Citation

Goss, P., E. Mamounas, R. Jakesz, C. Markopoulos, M. Dowsett, R. Peto, J. Godwin, and C. Davies. Aromatase Inhibitors (AIs) Versus Not (Placebo/Observation) as Late Extended Adjuvant Therapy for Postmenopausal Women with Early Stage Breast Cancer (BC): Overviews of Randomized Trials of AIs After Similar to 5 Years of Tamoxifen. 2009.

MLA (9th ed.) Citation

Goss, P., et al. Aromatase Inhibitors (AIs) Versus Not (Placebo/Observation) as Late Extended Adjuvant Therapy for Postmenopausal Women with Early Stage Breast Cancer (BC): Overviews of Randomized Trials of AIs After Similar to 5 Years of Tamoxifen. 2009.